In contrast, the expression of FCGR2A in the adrenocortical carcinoma, diffuse large B cell lymphoma, acute myeloid leukemia, pulmonary squamous carcinoma, and thymus cancer tissues was significantly lower than that of the corresponding adjacent tissues (Figure 4). This evidence concerns the gene FCGR2A and adrenal cortex carcinoma.